University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.
It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.
A PHASE III OPEN-LABEL RANDOMIZED STUDY OF MPDL3280A (Anti-PD-L1 ANTIBODY) IN COMBINATION WITH BEVACIZUMAB VERSUS SUNITINIB IN PATIENTS WITH UNTREATED ADVANCED RENAL CELL CARCINOMAView Trial
Studies on regulation of thyroid cell growth and functionView Trial
The beliefs of young people with rheumatic conditions about research priorities for adolescent rheumatology and their involvement in shaping the research agenda in this area. Developing a youth involvement strategy for the Barbara Ansell National Network for Adolescent Rheumatology (BANNAR)View Trial
A phase III double-blind placebo-controlled randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumoursView Trial
Mechanisms for the susceptibility to bacterial infection in those with influenzaView Trial
Birmingham and Newcastle Cohort Study of Primary Biliary Cirrhosis:A two centre proof of concept study in Primary Biliary Cirrhosis (PBC)View Trial
Use of venesected blood from patients with haemochromatosis to isolate and culture lmmune cellsView Trial
A Pilot Randomised Study to Compare Combination Antibiotic Therapy (Ciprofloxacin Doxycycline and Hydroxychloroquine) with Standard Therapy (Budesonide) in the Treatment of Active Crohn’s DiseaseView Trial
A Phase Ib Study of Eltrombopag and Azacitidine in Patients with High Risk Myelodysplastic Syndromes and Related DisordersView Trial
A Phase IIa Randomised Double Blind Placebo-controlled Parallel Group Study to Assess the Safety and Efficacy of 28 Day Oral administration of BAY 85-8501 in Patients with no-Cystic Fibrosis BronchiectasisView Trial